Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367119 · ClinicalTrials.gov registry record · NA
Ketamine Anesthesia in Electroconvulsive Therapy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT01367119: Completed NA study, sponsored by Mayo Clinic.
NCT01367119 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01367119, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Does the use of ketamine as the anesthetic medication in electroconvulsive therapy (ECT) accelerate the antidepressant effect of ECT? The study hypothesis was that depressed subjects receiving ECT with ketamine as the anesthetic agent would demonstrate a faster rate of improvement, defined as lower depression ratings after the second ECT than depressed patients receiving ECT with the usual anesthetic agent.
Interventions
- DRUG Ketamine
- DRUG methohexital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01367119
The ClinicalTrials.gov registry entry for NCT01367119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT01367119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01367119 about?
NCT01367119 is a clinical study titled "Ketamine Anesthesia in Electroconvulsive Therapy". Does the use of ketamine as the anesthetic medication in electroconvulsive therapy (ECT) accelerate the antidepressant effect of ECT? The study hypothesis was that depressed subjects receiving ECT with ketamine as the anesthetic agent would demonstrate a faster rate of improvement, defined as lower...
What is the current status of trial NCT01367119?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2011-05. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01367119?
The interventions under investigation include: Ketamine (DRUG), methohexital (DRUG).
Who is sponsoring clinical trial NCT01367119?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.